Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: a double‐blind, randomized, placebo‐controlled trial

D Riss, M Burian, A Wolf, V Kranebitter, A Kaider… - Head & …, 2015 - Wiley Online Library
Background The purpose of this study was to investigate the efficacy of bevacizumab
(“Avastin”) for the treatment of epistaxis in hereditary hemorrhagic telangiectasia (HHT) …

Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid-a double-blind placebo-controlled cross-over phase IIIB study

UW Geisthoff, UT Seyfert, M Kübler, B Bieg… - Thrombosis research, 2014 - Elsevier
Introduction Epistaxis is the most frequent manifestation in hereditary hemorrhagic
telangiectasia, in which no optimal treatment exists. It can lead to severe anemia and …

Angiographic embolization for the treatment of epistaxis: a review of 108 cases

L Elden, W Montanera, K Terbrugge… - … –Head and Neck …, 1994 - Wiley Online Library
Ninety‐seven patients were referred to the Toronto Hospital (Western Division) between
January 1984 and January 1992 for selective angiograpic embolization (108 embolizations …

Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre …

R Invernizzi, F Quaglia, C Klersy, F Pagella… - The Lancet …, 2015 - thelancet.com
Background Hereditary haemorrhagic telangiectasia is a genetic disease that leads to
multiregional angiodysplasia. Severe recurrent epistaxis is the most common presentation …

Clinical practice guideline: otitis media with effusion executive summary (update)

RM Rosenfeld, JJ Shin, SR Schwartz… - … –Head and Neck …, 2016 - journals.sagepub.com
The American Academy of Otolaryngology—Head and Neck Surgery Foundation has
published a supplement to this issue of Otolaryngology—Head and Neck Surgery featuring …

Epistaxis

LKS Tan, KH Calhoun - Medical Clinics of North America, 1999 - Elsevier
Patients presenting with epistaxis are anxious and fear bleeding to death. Although death
from epistaxis is rare, it can occur, and significant morbidity is relatively common. 5, 34 …

On the effectiveness of treatment options in epistaxis: an analysis of 678 interventions.

MB Soyka, G Nikolaou, K Rufibach, D Holzmann - Rhinology, 2011 - europepmc.org
Background Epistaxis represents one of the most common emergencies in ENT clinics
around the world. It creates great physical and emotional stress to the patient as well as a …